Xiangqian Su Selected Research

GATA2 Transcription Factor

9/2016	GATA binding protein 2 overexpression is associated with poor prognosis in KRAS mutant colorectal cancer.
1/2015	GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer.
6/2013	Expression and prognostic significance of GATA-binding protein 2 in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiangqian Su Research Topics

Disease

27	Stomach Neoplasms (Stomach Cancer) 01/2022 - 08/2014
23	Neoplasms (Cancer) 01/2022 - 02/2009
10	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 06/2013
6	Neoplasm Metastasis (Metastasis) 04/2022 - 02/2009
5	Adenocarcinoma 12/2021 - 02/2018
5	Flatulence 01/2020 - 03/2014
4	Infections 09/2021 - 02/2018
4	Rectal Neoplasms (Rectal Cancer) 06/2021 - 08/2014
4	Anastomotic Leak 03/2021 - 08/2014
3	Colonic Neoplasms (Colon Cancer) 01/2021 - 02/2009
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2019 - 02/2018
3	Carcinogenesis 01/2017 - 04/2013
2	Obesity 11/2019 - 08/2014
2	Hemorrhage 03/2019 - 02/2018
1	Turcot syndrome 12/2021
1	Coinfection 02/2019
1	Wounds and Injuries (Trauma) 02/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 02/2019
1	Pain (Aches) 02/2019
1	Fistula 02/2018
1	Lymphatic Metastasis 02/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2015

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2009
3	Competitive Endogenous RNAIBA 01/2022 - 04/2013
3	GATA2 Transcription FactorIBA 09/2016 - 06/2013
2	Indicators and Reagents (Reagents)IBA 04/2022 - 06/2013
2	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2013
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2009
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
2	Fluorouracil (Carac)FDA LinkGeneric 12/2021 - 01/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2017 - 08/2010
2	MicroRNAs (MicroRNA)IBA 01/2017 - 04/2013
2	Transcription Factors (Transcription Factor)IBA 01/2015 - 06/2013
1	Biological ProductsIBA 01/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	Circular RNAIBA 01/2022
1	Janus Kinase 2IBA 01/2022
1	PlatinumIBA 12/2021
1	Epithelial Cell Adhesion MoleculeIBA 09/2021
1	XELOXIBA 08/2021
1	Capecitabine (Xeloda)FDA Link 01/2021
1	N 30IBA 01/2020
1	Calcibiotic Root Canal SealerIBA 01/2018
1	Pharmaceutical PreparationsIBA 11/2017
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	3' Untranslated Regions (3' UTR)IBA 01/2017
1	Panitumumab (Vectibix)FDA Link 11/2016
1	Cetuximab (Erbitux)FDA Link 11/2016
1	ErbB Receptors (EGF Receptor)IBA 11/2016
1	VaccinesIBA 11/2016
1	Peptide LibraryIBA 11/2016
1	Humanized Monoclonal AntibodiesIBA 11/2016
1	Carcinoembryonic AntigenIBA 01/2016
1	PhosphoproteinsIBA 01/2014
1	HLA-DRB1 Chains (HLA DRB1)IBA 08/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 08/2010
1	Monoclonal AntibodiesIBA 02/2009
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2009

Therapy/Procedure

28	Gastrectomy 01/2022 - 08/2014
11	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 04/2016
6	Length of Stay 01/2020 - 03/2014
5	Adjuvant Chemotherapy 12/2021 - 01/2014
4	Therapeutics 04/2022 - 02/2009
4	Drug Therapy (Chemotherapy) 12/2021 - 11/2016
3	Neoadjuvant Therapy 12/2021 - 12/2019
3	Laparotomy 12/2018 - 08/2014
2	Colectomy 01/2021 - 11/2015
2	Immunotherapy 01/2020 - 11/2016
2	Gastroenterostomy 03/2019 - 02/2018
2	Conservative Treatment 03/2019 - 02/2018
2	Blood Transfusion (Blood Transfusions) 01/2015 - 08/2014
1	Folfox protocol 08/2021
1	Ligation 01/2020
1	Proctectomy 11/2019
1	Operative Time 02/2018
1	Radiotherapy 08/2014
1	Minor Surgical Procedures (Minor Surgery) 08/2014
1	Gastroscopes 02/2014